Tacrolimus works by binding to FKBP-12, a protein within cells. This forms a complex with calcium, calmodulin, and calcineurin, inhibiting the enzyme's phosphatase activity. This inhibition prevents the activation of nuclear factors like NF-AT and NF-κB, which are critical in T-cell activation. As a result, the production and release of cytokines such as interleukins (IL-1β to IL-10), tumor necrosis factor-alpha, and interferon-gamma are suppressed. Tacrolimus also blocks IL-2 receptor expression, reduces nitric oxide release, and promotes apoptosis and transforming growth factor-beta production, leading to decreased T-cell activation and immune response.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Tacrocap 1 is prescribed to prevent the rejection of transplanted organs, such as the liver, kidney, or heart. Organ rejection occurs when the immune system identifies the transplanted organ as foreign and attempts to attack it.
Tacrocap 1 contains Tacrolimus, which works by suppressing the activity of T and B lymphocytes—immune cells responsible for attacking foreign substances. By doing so, Tacrocap 1 helps prevent organ rejection and supports the body in accepting the transplanted organ.
Take Tacrocap 1 as directed by your doctor. Use the medication for the duration recommended based on your condition. While taking this medication, you may experience side effects such as nausea, diarrhea, headache, kidney problems, infection, fever, constipation, or high blood pressure. Most side effects are mild and resolve over time, but consult your doctor if they persist or worsen.
Inform your doctor if you are allergic to Tacrolimus or any other medicines. If you are pregnant or breastfeeding, seek medical advice before starting Tacrocap 1. Avoid alcohol while on this medication. Use caution when driving or operating machinery, as Tacrocap 1 may cause vision disturbances or nervous system issues.
Notify your doctor if you plan to receive a vaccine while taking this medication. Tacrocap 1 can increase the risk of infections or skin cancer due to its immune-suppressing effects.
Tacrocap 1 is an immunosuppressive agent. It works by blocking the release of certain chemicals in the body (such as T-cells) that trigger the immune response. It suppresses your body’s immune functions and enables your body to accept the transplanted organ. As a result, it manages the risk of graft rejection and increases the survival of the newly transplanted organ.
Tacrocap, an immunosuppressant that inhibits calcineurin, is prescribed to prevent organ rejection in adults and children undergoing liver, kidney, heart, or lung transplants. It is used alongside other immunosuppressive medications.
Adult Dosage Recommendations
Pediatric Dosage Recommendations
Note: Cystic fibrosis patients undergoing lung transplants may require higher doses due to reduced absorption.
Tacrocap should not be used in patients allergic to tacrolimus or polyoxyl 60 hydrogenated castor oil (HCO-60).
Tacrolimus can harm the fetus. Pregnant women should be informed of the risks.
Store below 30°C in a dry, well-lit place, away from moisture and out of children's reach.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.